Sulfuric Acid

Sulfuric Acid

SCHEMBL3843891

O=S(=O)(O)O.OCCON(OCCO)OCCO

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CA5A P35218 1/20 0.33
CA5B Q9Y2D0 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfamate SCHEMBL11063560 0.90 TSHR (0.40) CA5ACA5BTSHRMAPK1
SCHEMBL28591046 0.90 ALDH1A1 (0.31) TSHRMAPK1
SCHEMBL1232726 0.85 USP2 (0.33) TSHR
SCHEMBL30539 0.85 TSHR (0.44) TSHRMAPK1MEN1KMT2A
Dodecane SCHEMBL27447018 0.85 MEN1 (0.45) CA5ACA5BTSHRMAPK1MEN1
Sulfuric Acid SCHEMBL27137261 0.84 CA5A (0.30) CA5ACA5B
Methane SCHEMBL29262785 0.84 USP2 (0.32) TSHR
Sulfuric Acid SCHEMBL27153894 0.82 GAA (0.31)
Iodide SCHEMBL5874477 0.82 TSHR (0.41) TSHRMAPK1MEN1KMT2A
Ammonia Solution, Strong SCHEMBL5393633 0.82 TSHR (0.41) TSHRMAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5707433-A CARBON BLACK, POLYOXYETHYLENE LAURYL ETHER PHOSPHATE, SODIUM HYDROXIDE, ETHYLENE GLYCOL, PRESERVATIVES, GLYCEROL AND WATER FUJI PIGMENT CO., LTD. (JP) 1998-01-13 US claimed
US-4133779-A AMINE OXIDE THE PROCTER & GAMBLE COMPANY (US) 1979-01-09 US claimed
US-11939521-B2 Reuse of hypersaline brine with ionic liquids SAUDI ARABIAN OIL COMPANY (SA) 2024-03-26 US disclosed
US-20240059958-A1 REUSE OF HYPERSALINE BRINE WITH IONIC LIQUIDS SAUDI ARABIAN OIL COMPANY (SA) 2024-02-22 US disclosed
WO-2024039814-A1 REUSE OF HYPERSALINE BRINE WITH IONIC LIQUIDS SAUDI ARABIAN OIL COMPANY (SA) 2024-02-22 WO disclosed
WO-2023238500-A1 TREATMENT AGENT FOR CARBON FIBER PRECURSOR, AND CARBON FIBER PRECURSOR 竹本油脂株式会社 2023-12-14 WO disclosed
CN-115916936-A Fabric softening composition 高露洁-棕榄公司 2023-04-04 CN disclosed
US-9687387-B2 System and methods for treating ear disorders YAACOBI YOSEPH (US) 2017-06-27 US disclosed
US-20160022666-A1 Systems and Methods for Treating Ear Disorders and Formulations Therefor YAACOBI YOSEPH (US) 2016-01-28 US disclosed
EP-2968999-A1 SYSTEMS AND METHODS FOR TREATING EAR DISORDERS AND FORMULATIONS THEREFOR Yaacobi, Yoseph (US) 2016-01-20 EP disclosed
US-20140348959-A1 Formulations and Methods for Treating Ear Conditions PARTICLE SCIENCES, INC. 2014-11-27 US disclosed
EP-1515698-A4 LIPOSOMES CONTAINING BIOLOGICALLY ACTIVE COMPOUNDS PIEDMONT PHARMACEUTICALS LLC (US) 2005-09-14 EP disclosed
EP-1515698-A2 LIPOSOMES CONTAINING BIOLOGICALLY ACTIVE COMPOUNDS Piedmont Pharmaceuticals, LLC (US) 2005-03-23 EP disclosed
WO-2004000226-A2 LIPOSOMES CONTAINING BIOLOGICALLY ACTIVE COMPOUNDS PIEDMONT PHARMACEUTICALS, LLC (US) 2003-12-31 WO disclosed
US-20030235610-A1 Liposomes containing biologically active compounds PIEDMONT PHARMACEUTICALS, LLC 2003-12-25 US disclosed
US-20030091838-A1 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2003-05-15 US disclosed
EP-0370491-B1 Liposome comprising a novel phosphate as membrane constituent, liposome preparations and cosmetic preparations comprising said phosphate KAO CORP (JP) 1995-04-19 EP disclosed
US-5153000-A Moisture retaining KAO CORPORATION (JP) 1992-10-06 US disclosed
EP-0370491-A2 Liposome comprising a novel phosphate as membrane constituent, liposome preparations and cosmetic preparations comprising said phosphate KAO CORPORATION (JP) 1990-05-30 EP disclosed
US-4626429-A Conditioning of hair with amides of trialkylacetic acids COLGATE-PALMOLIVE COMPANY (US) 1986-12-02 US disclosed